AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 290: H978-H984, 2006. First published October 7, 2005; doi:10.1152/ajpheart.00538.2005
0363-6135/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow A corrigendum has been published
Right arrow All Versions of this Article:
290/3/H978    most recent
00538.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodriguez-Porcel, M.
Right arrow Articles by Lerman, L. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez-Porcel, M.
Right arrow Articles by Lerman, L. O.

Functional and structural remodeling of the myocardial microvasculature in early experimental hypertension

Martin Rodriguez-Porcel,1 Xiang-Yang Zhu,2 Alejandro R. Chade,2 Beatriz Amores-Arriaga,2 Noel M. Caplice,1 Erik L. Ritman,1,3 Amir Lerman,1 and Lilach O. Lerman1,2

Department of Internal Medicine, Divisions of 1Cardiovascular Diseases and 2Nephrology and Hypertension, and the 3Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Rochester, Minnesota

Submitted 23 May 2005 ; accepted in final form 2 October 2005


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Advanced hypertension (HT), associated with left ventricular hypertrophy (LVH), impairs myocardial microvascular function and structure and leads to increased myocardial hypoxia and growth factor activation. However, the effect of HT on microvascular architecture and its relation to microvascular function, before the development of LVH (early HT), remains unclear. By way of method, pigs were studied after 12 wk of renovascular HT (n = 7) or control (n = 7) animals. Myocardial microvascular function (blood volume and blood flow at baseline and in response to adenosine) was assessed by using electron beam computed tomography (CT). Microvascular architecture was subsequently studied ex vivo using micro-CT, and microvessels (diameter, <500 µm) were counted in situ in three-dimensional images (40-µm on-a-side cubic voxels). Myocardial expression of vascular endothelial growth factor, basic fibroblast growth factor, and hypoxia-inducible factor-1{alpha} were also measured. By way of results, left ventricular muscle mass was similar between the groups. The blood volume response to intravenous adenosine was attenuated in HT animals compared with normal animals (+7.4 ± 17.0 vs. +46.2 ± 12.3% compared with baseline, P = 0.48 and P = 0.01, respectively). Microvascular spatial density in HT animals was significantly elevated compared with normal animals (246 ± 26 vs. 125 ± 20 vessels/cm2, P < 0.05) and correlated inversely with the blood volume response to adenosine. Growth factors expression was increased in HT animals compared with control animals. In conclusion, early HT elicits changes in myocardial microvascular architecture, which are associated with microvascular dysfunction and precede changes in muscle mass. These observations underscore the direct and early effects of HT on the myocardial vasculature.

microcirculation; imaging; growth factors; microcomputed tomography

HYPERTENSION (HT) is a major risk factor for the development and progression of ischemic heart disease and increases the incidence of cardiac events (13). Advanced HT leads to the development of left ventricular (LV) hypertrophy (LVH), which has been associated with abnormal myocardial microvascular function, myocardial architectural changes (9, 41), and myocardial ischemia (41, 44, 45). However, the effect of early HT, before the development of LVH, on the myocardial microvasculature (structure and function) is not well understood. We have recently shown that early HT was associated with an impairment in both coronary vascular response to vasodilators (35) in vitro and myocardial perfusion response to cardiac vasodilator challenge in vivo (31, 33). However, it is yet unknown whether these functional alterations are coupled with changes in myocardial microvascular architecture. Furthermore, the adequacy of such changes in the architecture of myocardial microvessels to sustain their function remains to be elucidated.

Remodeling of the myocardial microvascular architecture, like neovascularization, may represent an adaptive response of the coronary circulation to episodes of myocardial ischemia or sustained pressure overload (37) and is regulated by growth factors and their receptors acting in concert (14). In particular, basic FGF (bFGF) (5, 16) and VEGF (36), regulated through hypoxia-inducible factor (HIF)-1{alpha} (26), can mediate compensatory neovascularization, as described in the aortic vasa-vasora in advanced HT (18) and in the coronary microvessels during the acute phase of adaptive cardiac hypertrophy (37). However, their role in early HT is yet to be determined.

One of the main factors that restricted investigation of the intramyocardial microcirculation is the limited availability of accurate and high-resolution imaging methods to study both myocardial microvascular function and three-dimensional (3-D) architecture in situ. Studies (32, 33) have previously shown that electron beam computed tomography (EBCT) allows accurate and noninvasive assessment of microvascular function in vivo, including myocardial perfusion, microvascular blood volume (BV), and permeability. In addition, microcomputed tomography (micro-CT) is a unique and high-resolution technique that allows investigation of small-scale structures within organs (12). Previous studies (2, 3, 34, 48) have shown that it permits assessment of the 3-D pattern of microvascular structure, spatial distribution, and connectivity. The combined application of these two powerful functional imaging techniques may therefore provide a unique insight into the concurrent functional and structural changes of the intramyocardial microcirculation at an early stage of HT and thereby provide an assessment of the functional impact and adequacy of microvasculature changes that take place in early HT.

Thus the present study was designed to test the hypothesis that early HT is associated with growth factor activation and changes in myocardial microvascular architecture, such as neovascularization, and, furthermore, that the increased spatial density of myocardial microvessels would correlate with the extent of their dysfunction in vivo (e.g., the degree of myocardial BV response to adenosine).


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
All procedures were approved by the Institutional Animal Care and Use Committee. Female domestic pigs (55–65 kg, 6 mo of age) were studied after 12 wk of observation. Group 1 had no intervention (n = 7 pigs), whereas in group 2 renovascular HT (n = 7 pigs) was induced by placing a local irritant stent in the left renal artery with consequent renal artery stenosis and development of hypertension (21). After 12 wk, animals were studied in vivo and blood samples were collected for measurement of plasma renin activity (PRA). Animals were then euthanized with intravenous pentobarbital sodium (20 ml of Sleepaway, Fort Dodge Laboratories, Fort Dodge, IA), and hearts were immediately removed and prepared for micro-CT, as previously described (34, 48). In addition, transmural pieces of the myocardium were flash frozen in liquid nitrogen or preserved in formalin for measurement of growth factor expression.

LV muscle mass and microvascular function via EBCT. For in vivo studies, animals were anesthetized with ketamine and xylazine (20 mg/kg and 2 mg/kg, respectively), intubated, and mechanically ventilated. Catheters were placed fluoroscopically in the aorta for measurement of mean arterial pressure (MAP) and in the right atrium for contrast media injections. Animals were then placed in the EBCT-scanning gantry (32, 33).

To exclude LVH, LV muscle mass was then measured (33). After allowing 15 min for stabilization, end-diastolic tomographic scans (from LV apex to base; slice thickness of 7 mm) were acquired by using ECG triggering. Scans were obtained during continuous infusion of iopamidol-370 (0.5 ml/kg, Squibb, Princeton, NJ), which enables the distinguishing of the endocardial border from the contrast-filled LV cavity during subsequent image analysis. The endocardial and epicardial borders were then manually traced, and LV muscle mass was calculated as a product of myocardial muscle area, density, and slice thickness, as previously shown (33).

For assessment of myocardial vascular function, scanning was performed in the EBCT flow mode in which 40 consecutive end-diastolic scans were obtained over 40 s (at 1–3 heart beat intervals) after a 2-s injection of iopamidol-370 (0.3 ml/kg) into the right atrium. Scans were obtained at baseline and after a 10-min intravenous adenosine infusion (400 µg·kg–1·min–1). Intravenous adenosine induces coronary artery vasodilation and is the most common pharmacological cardiac challenge used to assess myocardial perfusion reserve in clinical practice.

For image analysis, regions of interest were obtained from the LV cavity (for input function) and the anterior cardiac wall. The average tissue density (CT numbers) during and consequent to transit of contrast media was then measured in each region of interest and plotted against time, yielding time-density curves. Each myocardial time-density curve was then stripped into two components, representing the transit of contrast media through the intravascular and extravascular compartments of the myocardium, using an extended gamma-variate, curve-fitting algorithm (22) (Fig. 1). The area enclosed under each curve and its first moment (an index of mean transit time) were then computed (32, 33).


Figure 1
View larger version (19K):
[in this window]
[in a new window]
  		Fig. 1. Time-density curves consequent to transit of contrast media through anterior cardiac wall region of interest (raw data, red circles). Intra- (blue squares) and extravascular (green diamonds) components of original curve were depicted by using extended gamma-variate, curve-fitting algorithms. CT, computed tomography.

 
Intramyocardial BV was then calculated, using previously validated algorithms (22), as intramyocardial BV (ml blood/ml tissue): myocardial tissue area/LV cavity area, where "area" is the area under the corresponding curve. Intramyocardial BV, or vascular volume fraction, is a useful index of myocardial microvascular function in response to challenge (20, 27). Myocardial perfusion (in ml·min–1·g–1) was calculated (32, 33) as 60 x (BV/mean transit time)/[1.05 x (1 – BV)], where 1.05 g/ml is the specific density of the myocardium. Myocardial blood flow (MBF, in ml/min) was subsequently calculated as perfusion x LV muscle mass, and myocardial vascular resistance (MVR, in dyn·s–1·cm–5) as 80 x MAP/MBF (33).

Microvascular architecture via Micro-CT. Hearts were prepared as previously described (34, 48). The distal left anterior descending artery (LAD) was cannulated and perfused with a solution of 0.9% normal saline and heparin, and an intravascular contrast agent, radiopaque microfil silicone rubber (MV-122, Flow Tech, Carver, MA), was perfused through the cannulated LAD at a flow rate of 0.9 ml/min (at a physiological perfusion pressure of 100 ml/min) until it flowed freely from the myocardial veins. To allow for complete relaxation, the hearts were kept at 4°C for a day (34), after which a transmural portion of the LV myocardium (~2 x 1 x 1 cm3) was sectioned and prepared for scanning (34, 48).

The micro-CT scanner has been previously described (12, 34). Myocardial samples were scanned with the use of 0.49° angular increments, providing 721 views around 360° (34). Images were recorded, digitized, and transferred to a controlling computer. The 3-D volume images, which consisted of cubic voxels of 20 µm on a side, were displayed at 40-µm on-a-side resolution (to decrease computer memory demand), and the radiopacity of each voxel was represented by a 16-bit grayscale value.

Image analysis was performed by using the Analyze software package (Biomedical Imaging Resource, Mayo Clinic, Rochester, MN) (2, 34, 48). The myocardium was three-dimensionally oriented to obtain anatomically comparable samples for study. Subsequently, the myocardium was divided into two equal parts, classified as subendocardium and subepicardium.

In each region, microvessels (diameters, <500 µm) were counted in each tomographic section with the use of object counter software and classified as either small (diameters between 80 and 200 µm) or large (diameters between 201 and 500 µm). In addition, diameters of microvessels >200 µm were manually measured (48). To avoid errors due to noise, microvessels <80 µm (under 2 voxels) were excluded and considered to be below resolution.

In addition, with the use of a connectivity program, a single intramyocardial artery and its branches were tomographically isolated in each pig. Their branching pattern was visually assessed in 3-D images (34, 47, 48) and compared between the groups to evaluate whether a change in microvascular density (quantified in cross-sectional images) was due to an increase in parallel vessels or due to increased branching from existing vessels.

Myocardial tissue. Expression of HIF-1{alpha} (the inducible subunit of HIF-1) mRNA was measured by real-time RT-PCR. Protein expression of HIF-1{alpha} and VEGF were detected by Western blot analysis (48), whereas levels of bFGF were investigated by using ELISA (Quantikine, R & D Systems, Minneapolis, MN). For localization of FGF and VEGF, immunohistochemistry was used as previously described (4, 48). Mouse monoclonal antibodies anti-VEGF (A-20, dilution 1:100, R & D Systems) and bFGF-2 (No. 147, 1:100, R & D Systems) served as primary antibodies.

Western blot analysis. Equal protein (50–100 µg) of myocardial homogenate was dissolved in sodium dodecyl sulfate-polyacrylamide gels (12% or 4% to 20%) under reducing conditions and electrophoretically transferred onto polyvinylidene difluoride membranes (Bio-Rad, Hercules, CA). Membranes were blocked for 1 h in Tris-buffered saline with Tween 20 (TBST)-5% nonfat milk and incubated overnight at 4°C with antibodies against HIF-1{alpha} (1:1,000, Novus Biologicals, Littleton, CO) or VEGF (1:200, Santa Cruz Biotechnology, Santa Cruz, CA), as previously described from our laboratory (3, 48). After being washed with TBST, the membranes were incubated for 1 h with horseradish peroxidase-linked anti-rabbit antibody (1:5,000, Amersham Pharmacia Biotech, Piscataway, NJ) in TBST-5% nonfat milk, and proteins were visualized by electrochemiluminescence. {alpha}-Actin (1:1,000, Sigma, St. Louis, MO) was used as the loading control (47, 48).

Real-time RT-PCR. Total RNA was isolated from myocardial tissue with the Trizol (Invitrogen, Carlsbad, CA) method. cDNA was synthesized with the Invitrogen Superscript First-Strand Synthesis kit, as we have previously described (47, 48).

To measure the expression of HIF-1{alpha} mRNA, real-time quantitative RT-PCR was subsequently performed with a SYBR Green jumpstart Taq ReadyMix kit (Sigma). The porcine gene-specific sequence of HIF-1{alpha} was (left) 5'-AAC AAT TCA TCT GCG CCT TC-3' and (right) 5'-AAC AAT TCA TCT GCG CCT TC-3'. The relative amount of HIF-1{alpha} mRNA was normalized to an internal control GADPH and relative to a calibrator (normal), calculated by 2–{Delta}{Delta}CT. The sequence of the GADPH primer was (upper) 5'-GTC CAT GAA CCA TGA GAA GT-3' and (lower) 5'-GTC TTC TGG GTG GCA GTG AT-3' (47, 48).

Statistical analysis. Values are means ± SE. Comparisons were performed by using unpaired or paired Student's t-test (between and within groups, respectively). Statistical significance was accepted for P ≤ 0.05. Correlation analysis was performed by least-squares linear regression using the StatView 5.1 statistical software package (SAS Institute, Cary, NC).


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
In hypertensive animals, MAP was significantly increased compared with MAP in normal animals, whereas PRA and LV muscle mass were not significantly different between the groups (Table 1).


View this table:
[in this window]
[in a new window]
  		Table 1. Baseline characteristics, micro-CT-derived spatial density of microvessels and mean diameter of large intramyocardial microvessels, and EBCT-derived baseline characteristics of normal and HT pigs

 
Myocardial vascular architecture. The transmural spatial density of microvessels was significantly increased in HT animals compared with normal animals (246 ± 26 vs. 125 ± 20 vessels/cm2, P = 0.02). This resulted from increased spatial density in both the subepicardium and subendocardium (Fig. 2 and Table 1) but was significantly more pronounced in the subendocardial region (Fig. 2 and Table 1). In both regions, increases in microvascular density appeared to be secondary to increased branching of small microvessels because they were tomographically connected to the main vessel (Fig. 2, bottom). The microvascular density of large microvessels was also slightly but significantly increased in both subregions (Table 1), whereas their mean diameter was significantly reduced (P < 0.01, Table 1).


Figure 2
View larger version (66K):
[in this window]
[in a new window]
  		Fig. 2. Top: representative three-dimensional (3-D) images of transmural myocardium in normal and hypertensive (HT) pigs. Samples were scanned with micro-CT, reconstructed at resolution of 20-µm on-a-side cubic voxels and displayed at 40-µm on-a-side spatial resolution. Bottom: representative 3-D images of tomographically isolated intramyocardial coronary arteries, displayed at 20-µm on-a-side resolution, of normal and HT pigs.

 
Myocardial vascular function. Baseline BV, MBF, and MVR were not significantly different between normal and HT animals (Table 1). Matched datasets of functional responses and vessel density were available in seven HT and five control animals. The increase in BV and MBF in response to intravenous adenosine was blunted in HT animals, compared with normal animals, and was not significantly different from baseline (Fig. 3, top). MVR significantly decreased in response to adenosine in normal animals, but this decrease was blunted in HT animals (–27.7 ± 5.8 vs. –11.4 ± 11.8% compared with baseline, P = 0.02 and P = 0.16, respectively).


Figure 3
View larger version (28K):
[in this window]
[in a new window]
  		Fig. 3. Top: electron beam CT (EBCT)-derived myocardial blood volume (BV, left) and myocardial blood flow (MBF, right) responses to adenosine (in % change compared with baseline) in normal (n = 5) and HT (n = 7) animals. *P < 0.05 compared with baseline. Bottom: correlation between micro-CT-measured microvascular density and EBCT-derived BV response to adenosine in anterior wall of control (left) and HT (right) animals, showing that in HT animals, but not in control, there was significant inverse correlation between microvascular structure and function.

 
Interestingly, HT animals that showed the greatest increase in vessel density also showed the most attenuated BV response to adenosine. Furthermore, this relationship disclosed a significant inverse correlation between the spatial density of myocardial microvessels and the functional BV responses to adenosine in the anterior wall of HT animals (r = –0.75, P = 0.04, Fig. 3, bottom right) but not in normal animals (r = 0.01, P = 0.85, Fig. 3, bottom left).

Ex vivo studies. HT animals showed increased HIF-1{alpha} protein expression compared with controls (Fig. 4) with a tendency for an elevation of mRNA levels. Myocardial levels and expression of bFGF (in vascular smooth muscle cells and myocytes) and VEGF (in endothelial cells) were significantly increased in HT animals compared with normal animals and distributed uniformly throughout the myocardium (Fig. 5).


Figure 4
View larger version (39K):
[in this window]
[in a new window]
  		Fig. 4. Expression of hypoxia-inducible factor (HIF)-1{alpha} mRNA (top) and protein (bottom) in normal and HT pigs. *P < 0.05 compared with normal animals.

 

Figure 5
View larger version (41K):
[in this window]
[in a new window]
  		Fig. 5. Left: protein expression of VEGF (Western blot analysis and immunohistochemistry) in transmural myocardium of normal and HT pigs. Right: level (ELISA) and immunohistochemistry of basic FGF (bFGF) in transmural myocardium of normal and HT pigs. Myocardial expression of both bFGF and VEGF was significantly increased in HT animals. Immunohistochemistry showed that bFGF is expressed mainly in vascular smooth muscle cells and myocytes, and VEGF in endothelial cells, and that their increased expression appears to be uniform throughout myocardium. *P < 0.05 compared with normal animals.

 

   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
This study demonstrates that experimental HT induces changes in myocardial microvascular architecture and function in association with activation of growth factors, which precede the development of LVH.

HT is a major risk factor and leads to increased incidence of cardiovascular events (1, 25). HT is characterized by coronary endothelial dysfunction (42), abnormal myocardial perfusion regulation (10), and changes in myocardial microvascular architecture (9, 41). However, many of these changes were characterized in established or advanced stages of the disease, such as in the presence of LVH (9, 41). Thus it has been difficult to discern the effects of HT, per se, on the myocardium from the effects of LVH. In a model of swine renovascular hypertension, moderate increases in blood pressure for a relatively short period of time were not necessarily associated with increases in LV muscle mass (33, 35). Using this swine model of early HT, we have previously demonstrated that coronary endothelial dysfunction (35) and abnormal myocardial perfusion response to cardiac challenge (33) in early HT occur independently and before the development of LVH. The current study extends these prior observations and demonstrates that similar to microvascular dysfunction (represented in abnormal BV response to cardiac challenge), myocardial architectural changes in HT are initiated in the early stages of the disease and precede an increase in LV muscle mass, implying a direct effect of HT on both myocardial architecture and function.

To visualize and quantify the 3-D architecture of the myocardial microvasculature, we employed a unique, high-resolution micro-CT technique, which enabled detection of vessel size-specific alterations (2, 34, 48). Previous studies (34, 47) have described the capability of micro-CT to detect changes in myocardial and renal microvascular architecture in diet-induced hypercholesterolemia and ischemia. Because of its high-resolution and image analysis capabilities, this technology permits the evaluation of organ microvasculature, its distribution pattern and connectivity (34, 47). Using this technique, we observed that the HT-induced neovascularization was mainly due to an increase in the number of microvessels <200 µm in diameter, which are largely responsible for myocardial vascular resistance, and was more pronounced in the subendocardial myocardium. Indeed, the subendocardial architectural changes observed in our study likely reflect the differential sensitivity of subendocardial microvessels to nitric oxide and superoxide anion (39) or the increased propensity of this region for ischemia (28).

The abnormal myocardial microvascular function seen in HT may be associated with episodes of myocardial ischemia (11) and thereby may upregulate the expression of HIF-1{alpha} (23). In addition, abnormal coronary endothelial function in early HT (35) likely contributes to tissue ischemia and increased hypoxia. These ischemic stimuli can subsequently trigger myocardial neovascularization by modulating the temporal and spatial expression and activity of a plethora of growth factors and their receptors, which may play different roles in special aspects of vessel formation (24).

VEGF and bFGF are two key angiogenic factors that have been associated with HT (16, 46) and can be induced in pathophysiological states like chronic hypoxia (15, 48). This study extends prior observations and shows that a short duration of experimental HT is sufficient to induce significant myocardial ischemia in conjunction with VEGF and bFGF activation. These data are in agreement with prior studies that have shown that hypoxia serves as a powerful stimulus for the activation of VEGF (48) and bFGF (17, 43). In addition, myocardial neovascularization observed in our study could have also resulted from the synergistic interaction of VEGF and bFGF with alternative pathways, such as the local renin-angiotensin system (29) or other angiogenic factors.

In addition, we observed that HT was associated with a decrease in mean diameter of large microvessels, possibly due to inward growth of the vascular wall (negative vascular remodeling). Both the expression of angiogenic factors (16) and sensitivity to their growth stimulatory actions (6) may be enhanced in HT, which may contribute to vascular wall thickening (33). The increased number of small microvessels in the face of the decreased diameter of large microvessels might have been responsible for maintaining an unaltered basal microvascular blood volume and MBF, as previously observed in asymptomatic patients with borderline hypertension and no LVH (19). A slight, albeit not significant, increase in MBF that paralleled the increase in MAP likely sustained MVR.

The powerful combination of anatomical assessment via micro-CT with functional assessment of myocardial vascular function using EBCT allowed exploration of the relation between microvascular anatomy and function, which becomes critically important in view of the growing interest in therapeutic interventions targeted to increase the number of vessels (38) with the ultimate goal of improving organ function. Interestingly, we observed that microvascular neovascularization was inversely related to myocardial BV response to challenge in early HT, implying that an increase in the number of vessels did not translate into an improvement of myocardial function but, on the contrary, was associated with a worsening of the myocardial functional response. This may be due to abnormal features like disorganized architecture (8) and functional abnormalities (7) that can characterize newly generated microvessels and that may lead to altered regulation of flow to the myocardium. Nevertheless, because pathological neovascularization (as in HT) may have different mechanisms and effects than therapeutic neovascularization, these results should not be extrapolated to states where therapeutic angiogenesis might be beneficial.

Limitations. In the current study, we describe the microvascular changes that occur in early hypertension, mostly in vessels <200 µm in diameter. Although the resolution of micro-CT is as high as 4-µm voxels, limited computing power currently restricts routine handling of such large image files. In the current study, we used 40-µm voxels, and an enhancement of less than two adjacent voxels was considered as noise so that analysis was restricted to myocardial microvessels ≥80 µm. Rapid progress in memory size and computing power will likely allow future analysis of much smaller vessels.

It is also possible that microvessels might have been misclassified due to vascular remodeling or residual vascular tone with a consequent decline in the diameter of large microvessels. However, this is unlikely because our tissue preparation allows for full vascular relaxation, and the number of large microvessels was, in fact, increased rather than decreased.

In this study we used relatively young pigs, which may show greater potential for angiogenic responses compared with older animals (30). Notably, we also used female pigs, and estrogen has been reported to increase angiogenic response in HT (40). However, the pigs in our experimental groups were premenstrual, so that hormonal changes were unlikely to interfere with our results. Nevertheless, the possibility of effects from age and sex differences cannot be ruled out.

In summary, this study demonstrates that myocardial microvascular changes in early HT are associated with hypoxia and growth factor activation, as well as with microvascular functional changes. Importantly, we have shown that architecture changes in the myocardial microcirculation precede development of LVH and that an increase in its density did not translate into improved myocardial microvascular function in HT. These observations support the notion that early hypertension has direct functional and structural effects on the myocardial microcirculation. These findings have clinical implications because these changes occur after a relatively short period of moderate HT. These results underscore the functional significance of the architectural changes present in early HT and support early application of intensive preventive and therapeutic strategies in patients with HT.


   GRANTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
This study was supported by National Institutes of Health Grants HL-63282, HL-77131, HL-65342, and EB-000305 and by the American Heart Association.


   FOOTNOTES
 

Address for reprint requests and other correspondence: L. O. Lerman, Div. of Nephrology and Hypertension, Mayo Clinic, 200 First St. SW, Rochester, MN 55905 (e-mail: Lerman.Lilach{at}mayo.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Aronow WS, Epstein S, and Koenigsberg M. Usefulness of echocardiographic left ventricular hypertrophy and silent ischemia in predicting new cardiac events in elderly patients with systemic hypertension or coronary artery disease. Angiology 41: 189–193, 1990.[Abstract/Free Full Text]
  2. Bentley MD, Rodriguez-Porcel M, Lerman A, Sarafov MH, Romero JC, Pelaez LI, Grande JP, Ritman EL, and Lerman LO. Enhanced renal cortical vascularization in experimental hypercholesterolemia. Kidney Int 61: 1056–1063, 2002.[CrossRef][ISI][Medline]
  3. Chade AR, Bentley MD, Zhu X, Rodriguez-Porcel M, Niemeyer S, Amores-Arriaga B, Napoli C, Ritman EL, Lerman A, and Lerman LO. Antioxidant intervention prevents renal neovascularization in hypercholesterolemic pigs. J Am Soc Nephrol 15: 1816–1825, 2004.[Abstract/Free Full Text]
  4. Chade AR, Rodriguez-Porcel M, Grande JP, Krier JD, Lerman A, Romero JC, Napoli C, and Lerman LO. Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 106: 1165–1171, 2002.[Abstract/Free Full Text]
  5. Cottone S, Vadala A, Vella MC, Nardi E, Mule G, Contorno A, Riccobene R, and Cerasola G. Changes of plasma endothelin and growth factor levels, and of left ventricular mass, after chronic AT1-receptor blockade in human hypertension. Am J Hypertens 11: 548–553, 1998.[CrossRef][Medline]
  6. Damon DH, Lange DL, and Hattler BG. In vitro and in vivo vascular actions of basic fibroblast growth factor (bFGF) in normotensive and spontaneously hypertensive rats. J Cardiovasc Pharmacol 30: 278–284, 1997.[CrossRef][ISI][Medline]
  7. Dvorak HF, Brown LF, Detmar M, and Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029–1039, 1995.[Abstract]
  8. Gerwins P, Skoldenberg E, and Claesson-Welsh L. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit Rev Oncol Hematol 34: 185–194, 2000.[ISI][Medline]
  9. Gu JW, Fortepiani LA, Reckelhoff JF, Adair TH, Wang J, and Hall JE. Increased expression of vascular endothelial growth factor and capillary density in hearts of spontaneously hypertensive rats. Microcirculation 11: 689–697, 2004.[CrossRef][Medline]
  10. Harrison DG, Florentine MS, Brooks LA, Cooper SM, and Marcus ML. The effect of hypertension and left ventricular hypertrophy on the lower range of coronary autoregulation. Circulation 77: 1108–1115, 1988.[Abstract/Free Full Text]
  11. Hasdai D, Gibbons RJ, Holmes DR Jr, Higano ST, and Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 96: 3390–3395, 1997.[Abstract/Free Full Text]
  12. Jorgensen SM, Demirkaya O, and Ritman EL. Three-dimensional imaging of vasculature and parenchyma in intact rodent organs with X-ray micro-CT. Am J Physiol Heart Circ Physiol 275: H1103–H1114, 1998.[Abstract/Free Full Text]
  13. Kannel WB. Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevation to cardiovascular risk profile. Am Heart J 138: 205–210, 1999.[CrossRef][Medline]
  14. Kersten JR, Pagel PS, Chilian WM, and Warltier DC. Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia. Cardiovasc Res 43: 44–57, 1999.[Abstract/Free Full Text]
  15. Kosmidou I, Xagorari A, Roussos C, and Papapetropoulos A. Reactive oxygen species stimulate VEGF production from C2C12 skeletal myotubes through a PI3K/Akt pathway. Am J Physiol Lung Cell Mol Physiol 280: L585–L592, 2001.[Abstract/Free Full Text]
  16. Kurz C, Hefler L, Zeisler H, Schatten C, Husslein P, and Tempfer C. Maternal basic fibroblast growth factor serum levels are associated with pregnancy-induced hypertension. J Soc Gynecol Investig 8: 24–26, 2001.[Medline]
  17. Kuwabara K, Ogawa S, Matsumoto M, Koga S, Clauss M, Pinsky DJ, Lyn P, Leavy J, Witte L, Joseph-Silverstein J, Furie MB, Torcia G, Cozzolino F, Kamada T, and Stern DM. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Natl Acad Sci USA 92: 4606–4610, 1995.[Abstract/Free Full Text]
  18. Kuwahara F, Kai H, Tokuda K, Shibata R, Kusaba K, Tahara N, Niiyama H, Nagata T, and Imaizumi T. Hypoxia-inducible factor-1alpha/vascular endothelial growth factor pathway for adventitial vasa vasorum formation in hypertensive rat aorta. Hypertension 39: 46–50, 2002.[Abstract/Free Full Text]
  19. Laine H, Raitakari OT, Niinikoski H, Pitkanen OP, Iida H, Viikari J, Nuutila P, and Knuuti J. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol 32: 147–153, 1998.[Abstract/Free Full Text]
  20. Le DE, Bin JP, Coggins MP, Wei K, Lindner JR, and Kaul S. Relation between myocardial oxygen consumption and myocardial blood volume: a study using myocardial contrast echocardiography. J Am Soc Echocardiogr 15: 857–863, 2002.[CrossRef][Medline]
  21. Lerman LO, Schwartz RS, Grande JP, Sheedy PF II, and Romero JC. Noninvasive evaluation of a novel swine model of renal artery stenosis. J Am Soc Nephrol 10: 1455–1465, 1999.[Abstract/Free Full Text]
  22. Lerman LO, Siripornpitak S, Maffei NL, Sheedy PF II, and Ritman EL. Measurement of in vivo myocardial microcirculatory function with electron beam CT. J Comput Assist Tomogr 23: 390–398, 1999.[CrossRef][ISI][Medline]
  23. Li QF and Dai AG. Hypoxia-inducible factor-1 alpha regulates the role of vascular endothelial growth factor on pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Chin Med J (Engl) 117: 1023–1028, 2004.
  24. Matsumoto T, and Claesson-Welsh L. VEGF receptor signal transduction. Sci STKE 112: RE21, 2001.
  25. Mehler PS, Coll JR, Estacio R, Esler A, Schrier RW, and Hiatt WR. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation 107: 753–756, 2003.[Abstract/Free Full Text]
  26. Michiels C, De Leener F, Arnould T, Dieu M, and Remacle J. Hypoxia stimulates human endothelial cells to release smooth muscle cell mitogens: role of prostaglandins and bFGF. Exp Cell Res 213: 43–54, 1994.[CrossRef][ISI][Medline]
  27. Möhlenkamp S, Lerman LO, Lerman A, Behrenbeck TR, Katusic Z, Sheedy PF II, and Ritman EL. Minimally invasive evaluation of coronary microvascular function by electron beam computed tomography. Circulation 102: 2411–2416, 2000.[Abstract/Free Full Text]
  28. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, and Pennell DJ. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 346: 1948–1953, 2002.[Abstract/Free Full Text]
  29. Peifley KA and Winkles JA. Angiotensin II and endothelin-1 increase fibroblast growth factor-2 mRNA expression in vascular smooth muscle cells. Biochem Biophys Res Commun 242: 202–208, 1998.[CrossRef][ISI][Medline]
  30. Rakusan K, Flanagan MF, Geva T, Southern J, and Van Praagh R. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation 86: 38–46, 1992.[Abstract/Free Full Text]
  31. Rodriguez-Porcel M, Herrman J, Chade AR, Krier JD, Breen JF, Lerman A, and Lerman LO. Long-term antioxidant intervention improves myocardial microvascular function in experimental hypertension. Hypertension 43: 493–498, 2004.[Abstract/Free Full Text]
  32. Rodriguez-Porcel M, Lerman A, Best PJ, Krier JD, Napoli C, and Lerman LO. Hypercholesterolemia impairs myocardial perfusion and permeability: role of oxidative stress and endogenous scavenging activity. J Am Coll Cardiol 37: 806–815, 2001.
  33. Rodriguez-Porcel M, Lerman A, Herrmann J, Schwartz RS, Sawamura T, Condorelli M, Napoli C, and Lerman LO. Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculature. Cardiovasc Res 58: 213–221, 2003.[Abstract/Free Full Text]
  34. Rodriguez-Porcel M, Lerman A, Ritman EL, Wilson SW, Best PJM, and Lerman LO. Altered microvascular structure in experimental hypercholesterolemia. Circulation 102: 2028–2030, 2000.[Abstract/Free Full Text]
  35. Rodriguez-Porcel M, Lerman LO, Herrmann J, Sawamura T, Napoli C, and Lerman A. Hypercholesterolemia and hypertension have synergistic deleterious effects on coronary endothelial function. Arterioscler Thromb Vasc Biol 23: 885–891, 2003.[Abstract/Free Full Text]
  36. Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct 26: 25–35, 2001.[CrossRef][ISI][Medline]
  37. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, and Walsh K. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115: 2108–2118, 2005.[CrossRef][ISI][Medline]
  38. Sim EK, Zhang L, Shim WS, Lim YL, and Ge R. Therapeutic angiogenesis for coronary artery disease. J Card Surg 17: 350–354, 2002.[Medline]
  39. Sorop O, Spaan JA, Sweeney TE, and VanBavel E. Effect of steady versus oscillating flow in porcine coronary arterioles. Involvement of NO and superoxide anion. Circ Res 22: 1344–1351, 2003.
  40. Stier CT Jr, Chander PN, Rosenfeld L, and Powers CA. Estrogen promotes microvascular pathology in female stroke-prone spontaneously hypertensive rats. Am J Physiol Endocrinol Metab 285: E232–E239, 2003.[Abstract/Free Full Text]
  41. Tomanek RJ, Palmer PJ, Peiffer GL, Schreiber KL, Eastham CL, and Marcus ML. Morphometry of canine coronary arteries, arterioles, and capillaries during hypertension and left ventricular hypertrophy. Circ Res 58: 38–46, 1986.[Abstract/Free Full Text]
  42. Treasure CB, Klein JL, Vita JA, Manoukian SV, Renwick GH, Selwyn AP, Ganz P, and Alexander RW. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 87: 86–93, 1993.[Abstract/Free Full Text]
  43. Wang L, Xiong M, Che D, Liu S, Hao C, and Zheng X. The effect of hypoxia on expression of basic fibroblast growth factor in pulmonary vascular pericytes. J Tongji Med Univ 20: 265–267, 2000.[Medline]
  44. Yamani MH and Massie BM. Hypertension, myocardial ischemia, and sudden death. Curr Opin Cardiol 9: 542–550, 1994.[ISI][Medline]
  45. Yurenev AP, DeQuattro V, Dubov PB, Ostroumov EN, Nikulin IA, Konyaeva EB, Balyakina EV, Atachanov SE, Kosenko AI, Popov EG, Gabbasov ZA, and Gulyaev VP. Silent myocardial ischemia in patients with essential hypertension. Am J Hypertens 5: 169S–174S, 1992.[Medline]
  46. Zacharieva S, Atanassova I, Orbetzova M, Kirilov G, Nachev E, Kalinov K, and Shigarminova R. Vascular endothelial growth factor (VEGF), prostaglandin E2 (PGE2) and active renin in hypertension of adrenal origin. J Endocrinol Invest 27: 742–746, 2004.[Medline]
  47. Zhu XY, Chade AR, Rodriguez-Porcel M, Bentley MD, Ritman EL, Lerman A, and Lerman LO. Cortical microvascular remodeling in the stenotic kidney: role of increased oxidative stress. Arterioscler Thromb Vasc Biol 24: 1854–1859, 2004.[Abstract/Free Full Text]
  48. Zhu XY, Rodriguez-Porcel M, Bentley MD, Chade AR, Sica V, Napoli C, Caplice N, Ritman EL, Lerman A, and Lerman LO. Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation 109: 2109–2115, 2004.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
X.-Y. Zhu, M. D. Bentley, A. R. Chade, E. L. Ritman, A. Lerman, and L. O. Lerman
Early changes in coronary artery wall structure detected by microcomputed tomography in experimental hypercholesterolemia
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1997 - H2003.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
E. Daghini, X.-Y. Zhu, D. Versari, M. D. Bentley, C. Napoli, A. Lerman, and L. O. Lerman
Antioxidant vitamins induce angiogenesis in the normal pig kidney
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F371 - F381.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. Mannheim, D. Versari, E. Daghini, M. Gossl, O. Galili, A. Chade, V. S. Rajkumar, E. L. Ritman, L. O. Lerman, and A. Lerman
Impaired myocardial perfusion reserve in experimental hypercholesterolemia is independent of myocardial neovascularization
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2449 - H2458.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
X.-Y. Zhu, E. Daghini, A. R. Chade, C. Napoli, E. L. Ritman, A. Lerman, and L. O. Lerman
Simvastatin Prevents Coronary Microvascular Remodeling in Renovascular Hypertensive Pigs
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1209 - 1217.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow A corrigendum has been published
Right arrow All Versions of this Article:
290/3/H978    most recent
00538.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodriguez-Porcel, M.
Right arrow Articles by Lerman, L. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez-Porcel, M.
Right arrow Articles by Lerman, L. O.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.